Page results
-
The information provided aims to address the questions you may have about surgical management of endometriosis.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.
File results
-
FOI/2023/0698 - Teatment of breast cancer
-
FOI/2023/0696 - Freedom of Information (FOI) requests/ staff details
-
FOI/2023/0692 - Trust's Five year strategy spend
-
FOI/2023/0691 - Integrated medicine
-
FOI/2023/0689 - Access to digital test results for patients
-
FOI/2023/0687 - Information Governance pay grades
-
FOI/2023/0686 - Hysteroscopy Inpatient and Outpatient pathways
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0569 - Treatment for Ruxolitinib